<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03781440</url>
  </required_header>
  <id_info>
    <org_study_id>47647</org_study_id>
    <nct_id>NCT03781440</nct_id>
  </id_info>
  <brief_title>Regional Anesthesia for Cardiothoracic Enhanced Recovery</brief_title>
  <acronym>RACER</acronym>
  <official_title>Regional Anesthesia for Cardiothoracic Enhanced Recovery for Patients Undergoing Cardiac Surgery Via Sternotomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The erector spinae plane block (ESPB) is a novel regional analgesic technique that provides
      pain relief with a peripheral nerve block catheter. The goal of this study is to see if
      bilateral ESPB catheters can improve clinical outcomes in patients undergoing cardiac surgery
      via sternotomy, such as decreasing the duration of postoperative mechanical ventilation, need
      for intravenous opioid medications, length of stay in the intensive care unit (ICU), and
      improving pain scores.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 30, 2019</start_date>
  <completion_date type="Anticipated">October 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">October 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Median time to extubation in patients with ESPB</measure>
    <time_frame>Duration of postoperative recovery (typically 1-2 weeks)</time_frame>
    <description>duration in mechanical ventilation in hours</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Length of stay in ICU</measure>
    <time_frame>Duration of postoperative recovery (typically 1-2 weeks</time_frame>
    <description>number of days spent in ICU</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Opioid Consumption</measure>
    <time_frame>Duration of postoperative recovery (typically 1-2 weeks)</time_frame>
    <description>IV and PO opioid requirements converted to morphine equivalent</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Determine average post-operative pain scores in patients with ESPB</measure>
    <time_frame>Duration of postoperative recovery (typically 1-2 weeks)</time_frame>
    <description>NRS scale of 0-10</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Opioid Use</condition>
  <condition>Anesthesia, Local</condition>
  <condition>Cardiac Disease</condition>
  <condition>Pain, Acute</condition>
  <arm_group>
    <arm_group_label>Bilateral ESP catheter with Lidocaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All participants will get the Erector Spinae Plane (ESP) catheters. Prior to transfer to the operating room, participants will receive bilateral ESP catheters at T7 level under ultrasound guidance. This arm is the treatment group and will receive lidocaine via alternating side automated infusion pump bolus dosing, continued until chest tube removal or postoperative day 5 (whichever occurs earliest).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bilateral ESP catheter with saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>All participants will get the Erector Spinae Plane (ESP) catheters. This arm is the control group and will have normal saline administered via ESP catheters, continued until chest tube removal or postoperative day 5 (whichever occurs earliest).</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Bilateral ESP catheter with lidocaine</intervention_name>
    <description>All participants will get the Erector Spinae Plane (ESP) catheters. Prior to transfer to the operating room, participants will receive bilateral ESP catheters at T7 level under ultrasound guidance. This arm is the treatment group and will receive lidocaine via alternating side automated infusion pump bolus dosing, continued until chest tube removal or postoperative day 5 (whichever occurs earliest).</description>
    <arm_group_label>Bilateral ESP catheter with Lidocaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Bilateral ESP catheter with saline</intervention_name>
    <description>All participants will get the Erector Spinae Plane (ESP) catheters. This arm is the control group and will have normal saline administered via ESP catheters, continued until chest tube removal or postoperative day 5 (whichever occurs earliest).</description>
    <arm_group_label>Bilateral ESP catheter with saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Give consent to participate in study

          -  planned sternotomy

          -  specific procedures: CABG (coronary artery bypass grafting) or AVR (aortic valve
             repair or replacement) or MVR (mitral valve repair or replacement) or combination of
             any of 2 of these

          -  Primary or first redo sternotomy

        Exclusion Criteria:

          -  Participants who cannot give consent

          -  Patients who are clinically unstable or require urgent/emergent intervention

          -  more than1 prior sternotomy

          -  planned aortic arch procedures

          -  preoperative coagulopathy (INR &gt;1.5, PTT &gt;35) or ongoing anticoagulation (heparin
             infusion, therapeutic low molecular weight heparin, warfarin, dual antiplatelet
             therapy)

          -  Severe ventricular dysfunction (left or right ventricle)

          -  Known heart failure (systolic or diastolic)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ban Tsui, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jessica Brodt, MD</last_name>
    <phone>350-331-1075</phone>
    <email>jbrodt@stanford.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Swaraoop Mistry, MS</last_name>
    <phone>4084993037</phone>
    <email>smistry3@stanford.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Archana Verma</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Wheeler M, Oderda GM, Ashburn MA, Lipman AG. Adverse events associated with postoperative opioid analgesia: a systematic review. J Pain. 2002 Jun;3(3):159-80.</citation>
    <PMID>14622770</PMID>
  </reference>
  <reference>
    <citation>Zhu F, Lee A, Chee YE. Fast-track cardiac care for adult cardiac surgical patients. Cochrane Database Syst Rev. 2012 Oct 17;10:CD003587. doi: 10.1002/14651858.CD003587.pub2. Review.</citation>
    <PMID>23076899</PMID>
  </reference>
  <reference>
    <citation>Baikoussis NG, Papakonstantinou NA, Verra C, Kakouris G, Chounti M, Hountis P, Dedeilias P, Argiriou M. Mechanisms of oxidative stress and myocardial protection during open-heart surgery. Ann Card Anaesth. 2015 Oct-Dec;18(4):555-64. doi: 10.4103/0971-9784.166465. Review.</citation>
    <PMID>26440242</PMID>
  </reference>
  <reference>
    <citation>Giomarelli P, Scolletta S, Borrelli E, Biagioli B. Myocardial and lung injury after cardiopulmonary bypass: role of interleukin (IL)-10. Ann Thorac Surg. 2003 Jul;76(1):117-23.</citation>
    <PMID>12842524</PMID>
  </reference>
  <reference>
    <citation>Fragiadakis GK, Gaudillière B, Ganio EA, Aghaeepour N, Tingle M, Nolan GP, Angst MS. Patient-specific Immune States before Surgery Are Strong Correlates of Surgical Recovery. Anesthesiology. 2015 Dec;123(6):1241-55. doi: 10.1097/ALN.0000000000000887.</citation>
    <PMID>26655308</PMID>
  </reference>
  <reference>
    <citation>Gaudillière B, Fragiadakis GK, Bruggner RV, Nicolau M, Finck R, Tingle M, Silva J, Ganio EA, Yeh CG, Maloney WJ, Huddleston JI, Goodman SB, Davis MM, Bendall SC, Fantl WJ, Angst MS, Nolan GP. Clinical recovery from surgery correlates with single-cell immune signatures. Sci Transl Med. 2014 Sep 24;6(255):255ra131. doi: 10.1126/scitranslmed.3009701.</citation>
    <PMID>25253674</PMID>
  </reference>
  <reference>
    <citation>Eljezi V, DʼOstrevy N. Local Anesthetic Diffusion of Bilateral Sternal Block After Cardiac Surgery. Reg Anesth Pain Med. 2017 May/Jun;42(3):418-419. doi: 10.1097/AAP.0000000000000577.</citation>
    <PMID>28419054</PMID>
  </reference>
  <reference>
    <citation>Chaudhary V, Chauhan S, Choudhury M, Kiran U, Vasdev S, Talwar S. Parasternal intercostal block with ropivacaine for postoperative analgesia in pediatric patients undergoing cardiac surgery: a double-blind, randomized, controlled study. J Cardiothorac Vasc Anesth. 2012 Jun;26(3):439-42. doi: 10.1053/j.jvca.2011.10.012. Epub 2011 Dec 16.</citation>
    <PMID>22176767</PMID>
  </reference>
  <reference>
    <citation>Olivier JF, Bracco D, Nguyen P, Le N, Noiseux N, Hemmerling T; Perioperative Cardiac Surgery Research Group (PeriCARG). A novel approach for pain management in cardiac surgery via median sternotomy: bilateral single-shot paravertebral blocks. Heart Surg Forum. 2007;10(5):E357-62.</citation>
    <PMID>17855198</PMID>
  </reference>
  <reference>
    <citation>Cantó M, Sánchez MJ, Casas MA, Bataller ML. Bilateral paravertebral blockade for conventional cardiac surgery. Anaesthesia. 2003 Apr;58(4):365-70.</citation>
    <PMID>12688271</PMID>
  </reference>
  <reference>
    <citation>Lockwood GG, Cabreros L, Banach D, Punjabi PP. Continuous bilateral thoracic paravertebral blockade for analgesia after cardiac surgery: a randomised, controlled trial. Perfusion. 2017 Oct;32(7):591-597. doi: 10.1177/0267659117715507. Epub 2017 Jun 7.</citation>
    <PMID>28592166</PMID>
  </reference>
  <reference>
    <citation>Svircevic V, Nierich AP, Moons KG, Diephuis JC, Ennema JJ, Brandon Bravo Bruinsma GJ, Kalkman CJ, van Dijk D. Thoracic epidural anesthesia for cardiac surgery: a randomized trial. Anesthesiology. 2011 Feb;114(2):262-70. doi: 10.1097/ALN.0b013e318201d2de.</citation>
    <PMID>21239976</PMID>
  </reference>
  <reference>
    <citation>Chakravarthy M, Thimmangowda P, Krishnamurthy J, Nadiminti S, Jawali V. Thoracic epidural anesthesia in cardiac surgical patients: a prospective audit of 2,113 cases. J Cardiothorac Vasc Anesth. 2005 Feb;19(1):44-8.</citation>
    <PMID>15747268</PMID>
  </reference>
  <reference>
    <citation>Forero M, Adhikary SD, Lopez H, Tsui C, Chin KJ. The Erector Spinae Plane Block: A Novel Analgesic Technique in Thoracic Neuropathic Pain. Reg Anesth Pain Med. 2016 Sep-Oct;41(5):621-7. doi: 10.1097/AAP.0000000000000451.</citation>
    <PMID>27501016</PMID>
  </reference>
  <reference>
    <citation>Kose HC, Kose SG, Thomas DT. Lumbar versus thoracic erector spinae plane block: Similar nomenclature, different mechanism of action. J Clin Anesth. 2018 Aug;48:1. doi: 10.1016/j.jclinane.2018.03.026. Epub 2018 Apr 9.</citation>
    <PMID>29649625</PMID>
  </reference>
  <reference>
    <citation>Wong J, Navaratnam M, Boltz G, Maeda K, Ramamurthi RJ, Tsui BCH. Bilateral continuous erector spinae plane blocks for sternotomy in a pediatric cardiac patient. J Clin Anesth. 2018 Jun;47:82-83. doi: 10.1016/j.jclinane.2018.03.020. Epub 2018 Apr 6.</citation>
    <PMID>29631111</PMID>
  </reference>
  <reference>
    <citation>Tsui BCH, Navaratnam M, Boltz G, Maeda K, Caruso TJ. Bilateral automatized intermittent bolus erector spinae plane analgesic blocks for sternotomy in a cardiac patient who underwent cardiopulmonary bypass: A new era of Cardiac Regional Anesthesia. J Clin Anesth. 2018 Aug;48:9-10. doi: 10.1016/j.jclinane.2018.04.005. Epub 2018 May 26.</citation>
    <PMID>29684728</PMID>
  </reference>
  <reference>
    <citation>Kain ZN, Fitch JC, Kirsch JR, Mets B, Pearl RG. Future of anesthesiology is perioperative medicine: a call for action. Anesthesiology. 2015 Jun;122(6):1192-5. doi: 10.1097/ALN.0000000000000680. Erratum in: Anesthesiology. 2015 Aug;123(2):492.</citation>
    <PMID>25886775</PMID>
  </reference>
  <verification_date>December 2018</verification_date>
  <study_first_submitted>December 18, 2018</study_first_submitted>
  <study_first_submitted_qc>December 18, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">December 19, 2018</study_first_posted>
  <last_update_submitted>May 7, 2019</last_update_submitted>
  <last_update_submitted_qc>May 7, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 9, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Chi-Ho Ban Tsui</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Acute Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

